These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8752864)

  • 1. [Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 3. The results against Pseudomonas aeruginosa].
    Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1996 May; 49(5):509-16. PubMed ID: 8752864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 2. The results against enterobacteriaceae].
    Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1996 Mar; 49(3):279-88. PubMed ID: 8935124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 1. Activities against Staphylococcus aureus].
    Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1996 Feb; 49(2):194-202. PubMed ID: 8721079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial activities of combination uses of cefpirome with various antibiotics in vitro against clinically isolated glucose non-fermentative gram-negative rods: part 1. the results against Pseudomonas aeruginosa].
    Suzuki Y; Koguchi M; Fukayama S; Ishihara R; Oda S; Deguchi K
    Jpn J Antibiot; 1996 Jan; 49(1):71-82. PubMed ID: 8851306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An in vitro study on combination effect of isepamicin and beta-lactam antibiotics].
    Kumagai K; Otsuki H; Nishibuchi M; Takeda Y
    Jpn J Antibiot; 1990 Sep; 43(9):1579-87. PubMed ID: 2124634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of beta-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa.
    Song W; Woo HJ; Kim JS; Lee KM
    Int J Antimicrob Agents; 2003 Jan; 21(1):8-12. PubMed ID: 12507832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synergistic activity of isepamicin and beta-lactam antibiotics against Pseudomonas aeruginosa in vitro and in vivo].
    Shiritani Y; Yamaji S; Aoki A; Saigusa M; Yokoiyama S; Gato S; Tsuji A
    Jpn J Antibiot; 1988 Nov; 41(11):1591-9. PubMed ID: 3145343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The resistance of recent clinical isolates against isepamycin, other aminoglycosides and injectable beta-lactams].
    O'Hara K; Nakamura A; Sawai T; Hosino K; Iwai Y; Nakamura S; Seto I
    Jpn J Antibiot; 2000 Jan; 53(1):46-59. PubMed ID: 10709145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro combination effect of pazufloxacin with various antibiotics against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus].
    Maekawa M; Takahashi K; Takahata M; Minami S
    Jpn J Antibiot; 2002 Aug; 55(4):440-5. PubMed ID: 12378872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of human albumin on bactericidal or antibacterial activities of cephems and monobactams].
    Saionji K
    Jpn J Antibiot; 1988 Oct; 41(10):1390-406. PubMed ID: 3144613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity of allicin alone and in combination with beta-lactams against Staphylococcus spp. and Pseudomonas aeruginosa.
    Cai Y; Wang R; Pei F; Liang BB
    J Antibiot (Tokyo); 2007 May; 60(5):335-8. PubMed ID: 17551215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of polymyxins in combination with β-lactams against clinical strains of Pseudomonas aeruginosa.
    Mitsugui CS; Tognim MC; Cardoso CL; Carrara-Marroni FE; Botelho Garcia L
    Int J Antimicrob Agents; 2011 Nov; 38(5):447-50. PubMed ID: 21872449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacteriological evaluation of combined effects of vancomycin and beta-lactams. II. Results against gram-negative rods].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1993 Nov; 46(11):946-52. PubMed ID: 8309070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro effect of various antibiotics: beta lactams, aminoglycosides and fluoroquinolones alone and in combination against P. aeruginosa isolated from patients with mucoviscidosis].
    Croize J; Gout JP; Robert J; Le Noc P
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):573-7. PubMed ID: 2508041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacteriological evaluation of combined effects of vancomycin and beta-lactams. I. Results against methicillin-resistant Staphylococcus aureus].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1993 Nov; 46(11):939-45. PubMed ID: 8309069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of temocillin in combination with other beta-lactam antibiotics.
    Verbist L; Verhaegen J
    Drugs; 1985; 29 Suppl 5():32-7. PubMed ID: 3928322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibacterial activities of isepamicin against fresh clinical isolates of gram-negative bacilli].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukamoto T
    Jpn J Antibiot; 1994 Aug; 47(8):1053-64. PubMed ID: 7933534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan.
    Cheng NC; Hsueh PR; Liu YC; Shyr JM; Huang WK; Teng LJ; Liu CY
    Microb Drug Resist; 2005; 11(4):330-41. PubMed ID: 16359192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibacterial activities and PK/PD parameters of aminoglycosides against recent clinical isolates of gram-negative rods].
    Okubo T; Iyobe S
    Jpn J Antibiot; 2002 Oct; 55(5):514-23. PubMed ID: 12532635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.